Biology Reference
In-Depth Information
Baldwin BR, Zhang CO, Keay S (2000) Cloning and epitope mapping of a functional partial
fusion receptor for human cytomegalovirus gH. J Gen Virol 81:27-35
Beersma MF, Wertheim-van Dillen PM, Feltkamp TE (1990) The influence of HLA-B27 on the
infectivity of cytomegalovirus for mouse fibroblasts. Scand J Rheumatol Suppl 87:102-103
Beersma MF, Wertheim-van Dillen PM, Geelen JL, Feltkamp TE (1991) Expression of HLA class
I heavy chains and beta 2-microglobulin does not affect human cytomegalovirus infectivity.
J Gen Virol 72:2757-2764
Beersma MF, Bijlmakers MJ, Geelen JL, Feltkamp TE (1992) HLA-B27 as a receptor for cytome-
galovirus. Curr Eye Res 11 Suppl:141-146
Beutler T, Hoflich C, Stevens PA, Kruger DH, Prosch S (2003) Downregulation of the epidermal
growth factor receptor by human cytomegalovirus infection in human fetal lung fibroblasts.
Am J Respir Cell Mol Biol 28:86-94
Bodaghi B, Slobbe-van Drunen ME, Topilko A, Perret E, Vossen RC, van Dam-Mieras MC,
Zipeto D, Virelizier JL, LeHoang P, Bruggeman CA, Michelson S (1999) Entry of human
cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest
Ophthalmol Vis Sci 40:2598-2607
Boehme KW, Singh J, Perry ST, Compton T (2004) Human cytomegalovirus elicits a coordinated
cellular antiviral response via envelope glycoprotein B. J Virol 78:1202-1211
Boehme KW, Guerrero M, Compton T (2006) Human cytomegalovirus envelope glycoproteins B
and H are necessary for TLR2 activation in permissive cells. J Immunol 177:7094-7102
Bold S, Ohlin M, Garten W, Radsak K (1996) Structural domains involved in human cytomegalo-
virus glycoprotein B-mediated cell-cell fusion. J Gen Virol 77:2297-2302
Boyle KA, Compton T (1998) Receptor-binding properties of a soluble form of human cytomega-
lovirus glycoprotein B. J Virol 72:1826-1833
Browne EP, Wing B, Coleman D, Shenk T (2001) Altered cellular mRNA levels in human cytome-
galovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol
75:12319-12330
Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I (2004) Toll-like receptor
4-dependent activation of dendritic cells by a retrovirus. J Virol 78:576-584
Cobbs CS, Soroceanu L, Denham S, Zhang W, Britt WJ, Pieper R, Kraus MH (2007) Human
cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasive-
ness. J Neurooncol Jun 23; [Epub ahead of print]
Compton T, Nepomuceno RR, Nowlin DM (1992) Human cytomegalovirus penetrates host cells
by pH-independent fusion at the cell surface. Virology 191:387-395
Compton T, Nowlin DM, Cooper NR (1993) Initiation of human cytomegalovirus infection
requires initial interaction with cell surface heparan sulfate. Virology 193:834-841
Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW (2003)
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like
receptor 2. J Virol 77:4588-4596
DeFilippis VR, Robinson B, Keck TM, Hansen SG, Nelson JA, Fruh KJ (2006) Interferon regula-
tory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infec-
tion. J Virol 80:1032-1037
DeMeritt IB, Milford LE, Yurochko AD (2004) Activation of the NF-kappaB pathway in human
cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early
promoter. J Virol 78:4498-4507
English EP, Chumanov RS, Gellman SH, Compton T (2006) Rational development of beta-peptide
inhibitors of human cytomegalovirus entry. J Biol Chem 281:2661-2667
Fairley JA, Baillie J, Bain M, Sinclair JH (2002) Human cytomegalovirus infection inhibits epider-
mal growth factor (EGF) signalling by targeting EGF receptors. J Gen Virol 83:2803-2810
Feire AL, Koss H, Compton T (2004) Cellular integrins function as entry receptors for human
cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA
101:15470-15475
Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM,
Maniatis T (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling
pathway. Nat Immunol 4:491-496
